The MarketWatch News Department was not involved in the creation of this content. WUXI, China, March 11, 2026 /PRNewswire/ -- LabConnect, a leading provider of technology-driven central laboratory ...

An overview of Pei Zhong’s work over the past several decades reveals how fundamental engineering research — often done far from the clinic — plays a critical role in shaping safer, more effective ...

A narrative review examines how generative AI tools such as large language models and vision-language models could assist precision oncology by interpreting genomic data, matching patients to clinical ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

AstraZeneca’s $15 billion pledge to its China operations highlights the country’s advantages. But other regions are also hoping to host more clinical studies. More and more multinational companies are ...

Share on Pinterest The novel AI platform could help to match cancer patients with potential clinical trials. Image credit: UCG/Getty Images About 1 in every 5 people around the world will develop ...

The Food and Drug Administration (FDA) has issued a new guidance document entitled “Enhancing Participation in Clinical Trials – Eligibility Criteria, Enrollment Practices, and Trial Decision.” The ...

A study found that NIH grant cuts under the Trump administration in 2025 have already led to the termination of 118 trials studying cancer, 97 studying infectious diseases and 140 testing new ...

Sickle cell disease, sleep disorders and lung cancer: these are just a few of the medical issues that were under investigation in at least 383 clinical trials that have had research grants terminated ...

When the Trump administration brutally cut federal funding for biomedical research earlier this year, at least 383 clinical trials that were already in progress were abruptly canceled, cutting off ...

NIH grant terminations disrupted 3.5% of active clinical trials, affecting over 74,000 participants and resulting in a $1.81 billion funding loss. The National Institute of Mental Health and the ...

Clinical trial sites often open and close rapidly, with 60% ceasing operations within the first year, impacting patient access. The high closure rate of trial sites reflects unique research objectives ...